Opiate Addiction Clinical Trial
Official title:
Randomized Controlled Trial on the Effectiveness of Immediate Versus Delayed Access to Hospital-based Addiction Services
Hypothesis: Patients who are addicted to opioids or alcohol will have reduced substance use,
health care utilization if they have immediate and convenient access to pharmacotherapy and
addiction counselling.
Summary: This randomized trial will compare two different interventions for 124 alcohol and
opioid-addicted patients admitted to either Women's Own Detox (WOD) at the University Health
Network or the Withdrawal Management Service (WMS) at Saint Michael's Hospital (SMH. The
Delayed Intervention group will receive a card with contact information for the St.
Michael's Hospital and Women's College Hospital addiction medicine services. The Rapid
Intervention group will be seen by an addiction physician from one of these services, within
a day or two of their admission to the WOD or the SMH WMS. The addiction physician will
prescribe buprenorphine or anti-alcohol medications, and the physician, nurse and/or
therapist will provide ongoing counseling, follow-up and shared care with the family
physician. Outcomes (measured at 6 and 12 months) include treatment retention, health care
utilization and cost, medications prescribed, and alcohol and opioid use.
n/a
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02539823 -
Acute and Short-term Effects of CBD on Cue-induced Craving in Drug-abstinent Heroin-dependent Humans
|
Phase 2 | |
Completed |
NCT00913770 -
Models of Screening, Brief Intervention With a Facilitated Referral to Treatment (SBIRT) for Opioid Patients in the Emergency Department
|
N/A | |
Completed |
NCT00929253 -
Efficacy of Computer Delivered Community Reinforcement Approach (CRA) (Bup II)
|
N/A | |
Terminated |
NCT02741076 -
Discontinuation vs Continuation of Long-term Opioid Therapy in Suboptimal and Optimal Responders With Chronic Pain
|
Phase 4 | |
Completed |
NCT03015597 -
Pilot Study of Contingency Management for Smoking Cessation
|
N/A | |
Completed |
NCT02571400 -
Prevalence and Predictors of Prolonged Post-surgical Opioid Use: a Prospective Observational Cohort Study
|
N/A | |
Terminated |
NCT00552578 -
Buprenorphine as a Treatment in Opiate Dependent Pain Patients
|
Phase 4 | |
Completed |
NCT00253890 -
Insomnia and Drug Relapse Risk
|
Phase 3 | |
Completed |
NCT02667158 -
A Survey to Eval the Relation Between Doctor/Pharmacy Shopping and Outcomes Suggestive of Misuse, Abuse and/or Diversion
|
||
Completed |
NCT02667210 -
Study to Eval Relation Btw Doctor/Pharmacy Shopping & Outcomes of Misuse, Diversion, Abuse, Addiction by Med Rec Review
|
||
Active, not recruiting |
NCT01021566 -
Opiate Detoxification Using the Combined Hemoperfusion-hemodialysis
|
Phase 3 | |
Withdrawn |
NCT01015066 -
Comparison of Buprenorphine/Naloxone With Naltrexone in Opioid Dependent Adolescents
|
Phase 4 | |
Completed |
NCT02660619 -
Validation of PRISM-5-Op, Measure Of Addiction To Prescription Opioid Medication
|
||
Active, not recruiting |
NCT02751762 -
A Prospective Investigation of the Risks of Opioid Misuse, Abuse, and Addiction Among Patients Treated With Opioids for the Treatment of Chronic Pain
|
||
Completed |
NCT02657148 -
Immediate Postpartum Nexplanon Placement in Opioid Dependent Women
|
||
Completed |
NCT02362256 -
The Comparison of Stress Response to Rapid Opioid Detoxification Applying Different Methods of Opioid Antagonism
|
N/A | |
Completed |
NCT01605539 -
Acute and Short-term Effects of Cannabidiol Admin on Cue-induced Craving in Drug-abstinent Heroin Dependent Humans
|
Phase 2 | |
Completed |
NCT00204243 -
Naltrexone Implants vs. MMT Among Inmates in the Norwegian Correctional Services
|
Phase 2 | |
Completed |
NCT02667262 -
An Observational Study to Develop Algorithms for Identifying Opioid Abuse and Addiction Based on Admin Claims Data
|
||
Completed |
NCT00829777 -
Safety Study of Intravenous 6β-Naltrexol (AIKO-150) in Opioid-Dependent Subjects
|
Phase 1 |